Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus (SLE) is a highly heterogeneous autoimmune disease characterized by fluctuating activity, multi-organ involvement, and variable responses to therapy. This paper presents a conceptual interpretation of SLE as a long-term systems transition from a Universal Resonance Model (URM) perspective. Disease dynamics are described in terms of declining resilience, maladaptive resonance between interacting physiological loops (interferon signaling, B-cell activity, complement, vascular regulation, and neuroendocrine–autonomic modulation), and eventual consolidation into organ-specific locked states. Biomarkers are interpreted as phase markers and instability signals rather than static disease labels, and therapeutic effects are viewed as inherently phase-dependent and critically timing-sensitive. Conceptual framework only; no new experimental, clinical, or epidemiological data are included.
No takes yet. Share an insight, caveat, or question.
Anita Domargård (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: